Pixie Dust Technologies, Inc. announced a joint research agreement with Tohoku University School of Medicine (the "University") for the purpose of developing and commercializing certain non-pharmaceutical skin disease treatments using wave control technology.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 USD | +2.54% | -1.42% | -65.19% |
Mar. 13 | Pixie Dust Technologies Announces Chief Financial Officer Changes | CI |
Feb. 26 | Pixie Dust Technologies, Inc. Announces Amendment to Loan Agreement | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.19% | 34.7M | |
-13.00% | 193B | |
+2.64% | 167B | |
+4.80% | 160B | |
+8.08% | 104B | |
+34.79% | 83.55B | |
+12.22% | 82.75B | |
-4.57% | 72.35B | |
-22.80% | 54.73B | |
-7.68% | 43.68B |
- Stock Market
- Equities
- PXDT Stock
- News Pixie Dust Technologies, Inc.
- Pixie Dust Technologies, Inc. Announces Collaborative Research Agreement with Tohoku University School of Medicine